
원료의약품
Risperidone (리스페리돈)
KDMF APIs
Risperidone
품목명 (한글) | 리스페리돈 |
|---|---|
분류 | 중추신경계 |
CAS No. | 106266-06-2 |
KDMF 등록번호 | 20151130-10-C-349-20 20070521-10-C-231-14(1) |
제조원 | Mylan Laboratories Limited Aurobindo Pharma ltd. |
규격 | EP |
품목 정보
IUPAC Name | RAPZEAPATHNIPO-UHFFFAOYSA-N |
|---|---|
Description | Risperidone is a second-generation antipsychotic (SGA) medication used in the treatment of a number of mood and mental health conditions including schizophrenia, bipolar mania, and as an adjunct in severe depression for example. It is one of the most widely used SGAs. Schizophrenia and various mood disorders are thought to be caused by an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively. Risperidone is thought to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain. Risperidone binds with a very high affinity to 5-HT2A receptors, approximately 10-20 fold greater than the drug's binding affinity to D2 receptors |
Certificate of Analysis | If you need more information, please contact us. |
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)